303 related articles for article (PubMed ID: 24872439)
21. MicroRNA-183 regulates Ezrin expression in lung cancer cells.
Wang G; Mao W; Zheng S
FEBS Lett; 2008 Oct; 582(25-26):3663-8. PubMed ID: 18840437
[TBL] [Abstract][Full Text] [Related]
22. MicroRNA-modulated autophagic signaling networks in cancer.
Fu LL; Wen X; Bao JK; Liu B
Int J Biochem Cell Biol; 2012 May; 44(5):733-6. PubMed ID: 22342941
[TBL] [Abstract][Full Text] [Related]
23. The emerging role of microRNAs in resistance to lung cancer treatments.
MacDonagh L; Gray SG; Finn SP; Cuffe S; O'Byrne KJ; Barr MP
Cancer Treat Rev; 2015 Feb; 41(2):160-9. PubMed ID: 25592062
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the MIR155 host gene in physiological and pathological processes.
Elton TS; Selemon H; Elton SM; Parinandi NL
Gene; 2013 Dec; 532(1):1-12. PubMed ID: 23246696
[TBL] [Abstract][Full Text] [Related]
25. [Methylation of some miRNA genes is involved in the regulation of their target genes RAR-beta2 and NKIRAS1 expression in lung cancer].
Khodyrev DS; Pronina IV; Rykov SV; Beresneva EV; Fridman MV; Kazubskaia TP; Loginov VI; Braga ÉA
Mol Biol (Mosk); 2012; 46(5):773-85. PubMed ID: 23156677
[TBL] [Abstract][Full Text] [Related]
26. miR-27a regulates the self renewal of the H446 small cell lung cancer cell line in vitro.
Miao Y; Li J; Qiu X; Li Y; Wang Z; Luan Y
Oncol Rep; 2013 Jan; 29(1):161-8. PubMed ID: 23117485
[TBL] [Abstract][Full Text] [Related]
27. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: implications for outcomes and histologic classification.
Díaz-García CV; Agudo-López A; Pérez C; López-Martín JA; Rodríguez-Peralto JL; de Castro J; Cortijo A; Martínez-Villanueva M; Iglesias L; García-Carbonero R; Fresno Vara JA; Gámez-Pozo A; Palacios J; Cortés-Funes H; Paz-Ares L; Agulló-Ortuño MT
Carcinogenesis; 2013 May; 34(5):1031-8. PubMed ID: 23349018
[TBL] [Abstract][Full Text] [Related]
28. Identification of miR-374a as a prognostic marker for survival in patients with early-stage nonsmall cell lung cancer.
Võsa U; Vooder T; Kolde R; Fischer K; Välk K; Tõnisson N; Roosipuu R; Vilo J; Metspalu A; Annilo T
Genes Chromosomes Cancer; 2011 Oct; 50(10):812-22. PubMed ID: 21748820
[TBL] [Abstract][Full Text] [Related]
29. miRNAs in lung cancer: a link to aging.
Zagryazhskaya A; Zhivotovsky B
Ageing Res Rev; 2014 Sep; 17():54-67. PubMed ID: 24631464
[TBL] [Abstract][Full Text] [Related]
30. Non-small-cell lung cancer and miRNAs: novel biomarkers and promising tools for treatment.
Feng B; Zhang K; Wang R; Chen L
Clin Sci (Lond); 2015 May; 128(10):619-34. PubMed ID: 25760961
[TBL] [Abstract][Full Text] [Related]
31. let-7 and miR-17-92: small-sized major players in lung cancer development.
Osada H; Takahashi T
Cancer Sci; 2011 Jan; 102(1):9-17. PubMed ID: 20735434
[TBL] [Abstract][Full Text] [Related]
32. miRNA-214 is related to invasiveness of human non-small cell lung cancer and directly regulates alpha protein kinase 2 expression.
Salim H; Arvanitis A; de Petris L; Kanter L; Hååg P; Zovko A; Özata DM; Lui WO; Lundholm L; Zhivotovsky B; Lewensohn R; Viktorsson K
Genes Chromosomes Cancer; 2013 Oct; 52(10):895-911. PubMed ID: 23929716
[TBL] [Abstract][Full Text] [Related]
33. A microRNA gene signature for identification of lung cancer.
Xue Z; Wen J; Chu X; Xue X
Surg Oncol; 2014 Sep; 23(3):126-31. PubMed ID: 25031224
[TBL] [Abstract][Full Text] [Related]
34. MicroRNAs in lung diseases: Recent findings and their pathophysiological implications.
Ebrahimi A; Sadroddiny E
Pulm Pharmacol Ther; 2015 Oct; 34():55-63. PubMed ID: 26319446
[TBL] [Abstract][Full Text] [Related]
35. MicroRNAs in non-small cell lung cancer and idiopathic pulmonary fibrosis.
Mizuno K; Mataki H; Seki N; Kumamoto T; Kamikawaji K; Inoue H
J Hum Genet; 2017 Jan; 62(1):57-65. PubMed ID: 27488441
[TBL] [Abstract][Full Text] [Related]
36. MicroRNAs in the development and pathobiology of uterine leiomyomata: does evidence support future strategies for clinical intervention?
Karmon AE; Cardozo ER; Rueda BR; Styer AK
Hum Reprod Update; 2014; 20(5):670-87. PubMed ID: 24706045
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA involvement in the pathogenesis and management of breast cancer.
Khoshnaw SM; Green AR; Powe DG; Ellis IO
J Clin Pathol; 2009 May; 62(5):422-8. PubMed ID: 19398594
[TBL] [Abstract][Full Text] [Related]
38. miRNA expression and its clinical implications for the prevention and diagnosis of non-small-cell lung cancer.
Gao W; Xu J; Shu YQ
Expert Rev Respir Med; 2011 Oct; 5(5):699-709. PubMed ID: 21955239
[TBL] [Abstract][Full Text] [Related]
39. Altered levels of the onco-microRNA 21 and the tumor-supressor microRNAs 143 and 145 in advanced rectal cancer indicate successful neoadjuvant chemoradiotherapy.
Drebber U; Lay M; Wedemeyer I; Vallböhmer D; Bollschweiler E; Brabender J; Mönig SP; Hölscher AH; Dienes HP; Odenthal M
Int J Oncol; 2011 Aug; 39(2):409-15. PubMed ID: 21567082
[TBL] [Abstract][Full Text] [Related]
40. MicroRNAs in cancer management and their modulation by dietary agents.
Karius T; Schnekenburger M; Dicato M; Diederich M
Biochem Pharmacol; 2012 Jun; 83(12):1591-601. PubMed ID: 22342289
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
